ALEC
ALEC
NASDAQ · Biotechnology

Alector Inc

$1.98
-0.06 (-2.94%)
As of Aug 15, 2:09 AM ET ·
Financial Highlights (FY 2026)
Revenue
23.45M
Net Income
-159,250,384
Gross Margin
Profit Margin
-679.2%
Rev Growth
-46.0%
D/E Ratio
0.32
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 64.5% 64.5%
Operating Margin -741.3% -667.2% 8.6% 8.1%
Profit Margin -679.2% -645.2% 9.4% 7.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 23.45M 43.41M 87.33M 87.17M
Gross Profit 56.35M 56.25M
Operating Income -173,798,993 -289,611,356 7.53M 7.07M
Net Income -159,250,384 -265,368,164 8.20M 6.12M
Gross Margin 64.5% 64.5%
Operating Margin -741.3% -667.2% 8.6% 8.1%
Profit Margin -679.2% -645.2% 9.4% 7.0%
Rev Growth -46.0% -46.0% +6.5% -4.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 27.29M 27.29M 37.32M 37.66M
Total Equity 86.32M 86.32M 74.11M 65.78M
D/E Ratio 0.32 0.32 0.50 0.57
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -167,444,142 -294,523,115 10.19M 12.10M
Free Cash Flow 6.96M 5.08M